Alyeska Investment Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-880
Closed -$765K 524
2018
Q2
$765K Sell
880
-2,293
-72% -$1.99M 0.01% 375
2018
Q1
$3.99M Buy
3,173
+375
+13% +$472K 0.03% 284
2017
Q4
$4.18M Buy
2,798
+2
+0.1% +$2.99K 0.03% 254
2017
Q3
$5.72M Buy
+2,796
New +$5.72M 0.04% 266
2015
Q4
Sell
-210
Closed -$499K 489
2015
Q3
$499K Buy
+210
New +$499K 0.01% 417